Navigation Links
What it might take to unravel the 'lean mean machine' that is cancer
Date:2/23/2010

tumour cell is very different from the healthy cell. It also tells us that it works in a programmed rather than a random way, and that it targets a significant part of the genome, rather than just single genes."

"It tells us that treating cancer will be far more complex than we imagined, as it will first involve understanding and reversing epigenetic change."

The findings are timely in that they coincide with very recent events and publications that have brought the concepts of the 'epigenome' and 'epigenetics' into world focus. In January 2010 the International Human Epigenome Consortium (IHEC) was launched in Paris (with Professor Clark on the interim steering Committee). Time magazine ran a feature on epigenetics in January, and Nature published two articles on the subject this month: one addressing the importance of IHEC and the urgency of pooling international mind power and resources; the other describing the infinite complexity of the project orders of magnitude more challenging than the Human Genome Project.

The ultimate aim of IHEC is to produce a map of the human epigenome. The initial intention is to map 1,000 epigenomes within a decade. This will provide a healthy tissue base against which to compare the epigenomes of diseased tissue.

The Human Genome Project, completed in March 2000, found that the human genome contains around 25,000 genes. It took 3 billion US dollars to map them. 1

We do not yet know how many variations the human epigenome is likely to contain certainly millions as a single person could have many epigenomes in a lifetime, or even in a day. 2 The technological advances and computational power necessary to map the epigenome, therefore, remain incalculable.

The project at Garvan involved an initial bioinformatics phase; a comparative tissue analysis phase; and a data analysis phase.

The bioinformatics phase analysed publicly available microarray datasets (glass slides co
'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Research Australia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Fish Oil Might Help Relieve MS
2. HIV Drug Might Fight Cancer
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Vitamin C Plus Fat Might Spur Cancer
5. Mathematics might save you a trip to the ER
6. Veggies Might Ward Off Age-Linked Vision Woes
7. Rating your pain from 0 to 10 might not help your doctor
8. Blood Marker Might Help Spot Early Liver Cancer
9. Hushed Genes Might Mean Higher Lung Cancer Risk
10. Mathematics might save you a trip to the ER
11. More Prostate Cancers Might Be Prevented
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... AR (PRWEB) May 05, 2015 ... is collaborating with American Eagle Outfitters on a ... enhance natural beauty. , For the debut ... with Aerie by American Eagle ; the ... brand's body-image campaign, called "Aerie REAL," uses models ...
(Date:5/5/2015)... May 05, 2015 May is National Osteoporosis ... Institute for Better Bone Health . Founded by Charles ... to educate both consumers and physicians about the latest advances ... bone health. , According to a study recently published by ... Americans are affected by osteoporosis and low bone mass. This ...
(Date:5/5/2015)... NovaSom, Inc., announced today that they ... with Ed Begley Jr., airing via Discovery Channel 3rd ... segment will focus on NovaSom, a leader in Obstructive ... their AccuSom® home sleep test, which is the only ... support and next-day test results and interpretation. , ...
(Date:5/5/2015)... 05, 2015 Care Logistics ... called “Medicare Breakeven Challenges? A Model to ... ,     Formulas for two critical ... but should be ,     A model ... space” and ensures sustained efficient operations , ...
(Date:5/5/2015)... Crawford Technologies announced today it has been awarded ... of the Business Marketing Association (BMA) for the redesign ... was presented to the CrawfordTech marketing team on Friday, May ... over 300 people in attendance. , “The launch of the ... a shift in focus for how our company communicates our ...
Breaking Medicine News(10 mins):Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 3
... OMRON HEALTHCARE Co., Ltd., a,subsidiary of Omron ... home,healthcare, and wellness products, has developed the ... release worldwide in,spring 2009., "HEM-SOLAR monitors ... blood pressure readings wherever sunlight is available," ...
... Renew Acclaimed Series, NEW YORK, March 12 ... of Life" are being inundated with calls,blogs, e-mails, faxes ... renewed. These are not just ordinary fans. Many of ... survivors who are not,used to giving up a fight. ...
... watch TVs or computers, study finds , , WEDNESDAY, March 12 ... far too many hours a week in front of TVs ... "screen time." , "The take-home message is that we have ... healthier alternatives in their neighborhoods," said study author Tracie A. ...
... 12 The Providence,Service Corporation (Nasdaq: PRSC ) ... statement for shares of its common stock on Form ... anticipates,that it will file the proposed shelf registration statement ... 10-K for the Year Ended,December 31, 2007; however, it ...
... the Johns Hopkins Kimmel Cancer Center have uncovered,clearly recognizable ... early-stage lung cancers that look like good,predictors of which ... The discovery, they say, could change the approach to ... a pea - which are known to recur,within five ...
... Do you remember the seventh song that played on ... us dont, thanks to a normal forgetting process that is ... Researchers at the Buck Institute now believe that this normal ... this effect is key to the profound memory loss associated ...
Cached Medicine News:Health News:Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors 2Health News:Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors 3Health News:Cancer Survivors Lobby Lifetime TV to Order More of 'Side Order of Life' 2Health News:Teens Spending Too Much Screen Time 2Health News:Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement 2Health News:DNA detectives find genetic markers for lung cancers most likely to recur 2Health News:Paradoxical Alzheimer's finding may shed new light on memory loss 2
(Date:5/5/2015)... Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today ... Co-founder, President, Chief Executive Officer and current Director, ... of the Board. Mr. Tussing replaces Benjamin S. ... and his role as Chairman and a member of ... for the President of the United States ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... the "Will Theranos Turn the Lab Industry Upside ... has received much praise along with a healthy dose ... public" with their potentially disruptive laboratory solution. Behind all ... Has Theranos scaled microfluidic technology across a comprehensive ...
(Date:5/4/2015)... -- Luminex Corporation (NASDAQ: LMNX ) today announced financial ... and operating highlights include the following: , Consolidated ... over the first quarter of 2014. , First quarter ... the first quarter of 2014. , Consolidated gross profit ... , GAAP net income for the first quarter was ...
Breaking Medicine Technology:Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 2Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 3Will Theranos Turn the Lab Industry Upside Down? 2Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11
... with active moderate to severe rheumatoid arthritis (RA) inadequately ... (Humira ® ) and who were actively switched to ... at week 10, and sustained response through week 26 ... from the RESTART study were presented for the first ...
... PharmaNova, Inc., of Victor, NY , announced today that ... of $500,000 under the Qualifying Therapeutic Discovery Project (QTDP), which ... and Affordable Care Act of 2010. In July, PharmaNova applied ... NovaSperse(SM) -based nanoparticulate products. NovaSperse(SM) ...
Cached Medicine Technology:New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 2New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 3New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 4New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 5New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 6New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 7NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative 2
The 81483N projector operates off of DC power for maximum portability. The 20 watt halogen bulb with a specially designed reflector provides maximum brightness and portability....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 460 lines, NTSC output at 470 lines, focal length 30mm. 90mm length x 20mm diameter....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed ... cornea., ,The World Health Organisation (WHO) reports ... million people worldwide, however only 100,000 people ... is due to a combination of inadequate ...
Medicine Products: